statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing

Emergent BioSolutions and Janssen Pharmaceuticals settle disputes over SARS-CoV-2 vaccine manufacturing with a $50 million agreement, resolving all related claims and arbitration.
read more...

Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED)

Emergent BioSolutions has secured over $250 million in contract modifications from the ASPR at the U.S. Department of Health and Human Services. The funding ensures the supply of critical medical...

Key Takeaways From Emergent BioSolutions Analyst Ratings

Latest Ratings for EBS
 DateFirmActionFromTo Mar 2022Wells FargoMaintainsEqual-Weight Nov 2021Chardan CapitalMaintainsBuy Nov 2021BenchmarkDowngradesBuyHold
 View More Analyst Ratings for EBS...

What Is Going On With Emergent BioSolutions Shares?

On Thursday prior to the market open, Emergent BioSolutions announced it entered into a definitive agreement with Bora to sell the site for about $30 million.
read more...

Looking Into Emergent BioSolutions's Recent Short Interest

Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?

Emergent reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of losses of 83 cents by 171.08%.
read more...

Futures Rise As Dovish Fed Boosts Sentiment, Reverse Bizarre Post-Powell Slide

Futures Rise As Dovish Fed Boosts Sentiment, Reverse Bizarre Post-Powell Slide

 After a bizarre reversal when US stocks first slumped and then dumped after Powell's very dovish FOMC...

Commit To Purchase Emergent BioSolutions At $2, Earn 37.8% Annualized Using Options

Investors eyeing a purchase of Emergent BioSolutions Inc (EBS) shares, but tentative about paying the going market price of 2.33/share, might benefit from considering selling puts among the...

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Appoints Abigail Abbey Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of DirectorsWARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE...

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN  Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN Nasal Spray and build on its longstanding...

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Volume	1.59M
52-Wk High	$14.61
52-Wk Low	$1.42

EBS Emergent Biosolutions Inc

About

Feed

News

Sentiment

Earnings

Fundamentals